In addition, elevated de novo lipogenesis is considered to be a crucial factor in cancer development, and cancer therapeutic agents targeting DNL are being developed.[2, 3] DNL includes a coordinated series of enzymatic reactions.[1] The first step of this series of reactions is the conversion of citrate to acetyl‐CoA by ATP‐citrate lyase (ACLY). This evidence concerns the gene DNASE2 and cancer.